(NHTC) Natural Health Trend - Ratings and Ratios
Wellness, Beauty, Lifestyle, Home, Health
NHTC EPS (Earnings per Share)
NHTC Revenue
Description: NHTC Natural Health Trend
Natural Health Trends Corp. (NHTC) is a direct-selling and e-commerce company that operates under the NHT Global brand, offering a diverse range of personal care, wellness, and lifestyle products. The companys product portfolio includes a variety of wellness supplements, such as dietary and nutritional supplements, vitamins, and minerals, as well as herbal products. Additionally, NHTC provides beauty products, including age-defying and hydrating skincare products, and lifestyle products like weight management and energy enhancing supplements.
The companys product offerings also extend to home appliances, daily care products, and at-home testing kits for measuring various biomarkers related to overall well-being. NHTC sells its products directly to consumers through various channels, including e-commerce platforms, in multiple regions worldwide, including North America, Asia, and Europe. With a history dating back to 1988, the company has established a significant presence in the global market, leveraging its direct-selling and e-commerce capabilities to reach a broad customer base.
From a market perspective, NHTC operates within the personal care products industry, a sector characterized by a growing demand for wellness and health-related products. The companys business model, which combines direct selling with e-commerce, allows it to maintain a competitive edge in a rapidly evolving market landscape. With a market capitalization of $57.57 million, NHTCs stock is closely watched by investors seeking exposure to the personal care and wellness industry.
Analyzing the
Based on the available data, a forecast for NHTC could be constructed by analyzing the intersection of technical and fundamental indicators. Given the current downtrend and high P/E ratio, a cautious outlook is warranted. However, if NHTC can demonstrate improved profitability and effectively manage its product offerings and distribution channels, there may be potential for a turnaround. A potential price target could be around $5.50, representing a 20% increase from current levels, contingent upon the companys ability to address its profitability concerns and capitalize on the growing demand for wellness products.
NHTC Stock Overview
Market Cap in USD | 50m |
Sub-Industry | Personal Care Products |
IPO / Inception | 1995-06-21 |
NHTC Stock Ratings
Growth Rating | 2.71% |
Fundamental | 25.7% |
Dividend Rating | 65.0% |
Return 12m vs S&P 500 | -37.2% |
Analyst Rating | - |
NHTC Dividends
Dividend Yield 12m | 17.86% |
Yield on Cost 5y | 29.20% |
Annual Growth 5y | 0.00% |
Payout Consistency | 84.0% |
Payout Ratio | 26.5% |
NHTC Growth Ratios
Growth Correlation 3m | -15% |
Growth Correlation 12m | -56.4% |
Growth Correlation 5y | 60.9% |
CAGR 5y | 9.77% |
CAGR/Max DD 5y | 0.18 |
Sharpe Ratio 12m | -0.11 |
Alpha | -33.33 |
Beta | 0.223 |
Volatility | 26.32% |
Current Volume | 3.9k |
Average Volume 20d | 28.2k |
Stop Loss | 4.1 (-5.7%) |
Signal | -3.42 |
Piotroski VR‑10 (Strict, 0-10) 1.5
Net Income (348.0k TTM) > 0 and > 6% of Revenue (6% = 2.53m TTM) |
FCFTA -0.08 (>2.0%) and ΔFCFTA -0.55pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 61.57% (prev 80.90%; Δ -19.33pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA -0.12 (>3.0%) and CFO -5.50m <= Net Income 348.0k (YES >=105%, WARN >=100%) |
NO Net Debt/EBITDA fails (EBITDA <= 0) |
Current Ratio 2.73 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (11.5m) change vs 12m ago 0.12% (target <= -2.0% for YES) |
Gross Margin 73.97% (prev 74.04%; Δ -0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 78.92% (prev 69.89%; Δ 9.03pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' -0.68
(A) 0.57 = (Total Current Assets 40.9m - Total Current Liabilities 14.9m) / Total Assets 45.2m |
(B) -0.68 = Retained Earnings (Balance) -30.8m / Total Assets 45.2m |
(C) -0.03 = EBIT TTM -1.37m / Avg Total Assets 53.3m |
(D) -1.95 = Book Value of Equity -31.7m / Total Liabilities 16.3m |
Total Rating: -0.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 25.74
1. Piotroski 1.50pt = -3.50 |
2. FCF Yield -18.41% = -5.0 |
3. FCF Margin -8.14% = -3.05 |
4. Debt/Equity 0.08 = 2.50 |
5. Debt/Ebitda -1.93 = -2.50 |
6. ROIC - WACC -4.30% = -5.37 |
7. RoE 1.09% = 0.09 |
8. Rev. Trend -75.81% = -3.79 |
9. Rev. CAGR -6.24% = -1.04 |
10. EPS Trend -3.71% = -0.09 |
11. EPS CAGR -34.14% = -2.50 |
What is the price of NHTC shares?
Over the past week, the price has changed by +0.69%, over one month by -2.98%, over three months by -7.11% and over the past year by -26.06%.
Is Natural Health Trend a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NHTC is around 4.78 USD . This means that NHTC is currently overvalued and has a potential downside of 9.89%.
Is NHTC a buy, sell or hold?
What are the forecasts/targets for the NHTC price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 5.3 | 20.7% |
Last update: 2025-08-28 04:46
NHTC Fundamental Data Overview
CCE Cash And Equivalents = 34.2m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 146.0
P/S = 1.1982
P/B = 1.7475
Beta = 0.588
Revenue TTM = 42.1m USD
EBIT TTM = -1.37m USD
EBITDA TTM = -1.25m USD
Long Term Debt = 1.36m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.06m USD (from shortTermDebt, last quarter)
Debt = 2.42m USD (Calculated: Short Term 1.06m + Long Term 1.36m)
Net Debt = -8.29m USD (from netDebt column, last quarter)
Enterprise Value = 18.6m USD (50.4m + Debt 2.42m - CCE 34.2m)
Interest Coverage Ratio = unknown (Ebit TTM -1.37m / Interest Expense TTM 0.0)
FCF Yield = -18.41% (FCF TTM -3.42m / Enterprise Value 18.6m)
FCF Margin = -8.14% (FCF TTM -3.42m / Revenue TTM 42.1m)
Net Margin = 0.83% (Net Income TTM 348.0k / Revenue TTM 42.1m)
Gross Margin = 73.97% ((Revenue TTM 42.1m - Cost of Revenue TTM 11.0m) / Revenue TTM)
Tobins Q-Ratio = -0.59 (set to none) (Enterprise Value 18.6m / Book Value Of Equity -31.7m)
Interest Expense / Debt = 88.88% (Interest Expense 2.15m / Debt 2.42m)
Taxrate = 7.74% (from yearly Income Tax Expense: 48.0k / 620.0k)
NOPAT = -1.37m (EBIT -1.37m, no tax applied on loss)
Current Ratio = 2.73 (Total Current Assets 40.9m / Total Current Liabilities 14.9m)
Debt / Equity = 0.08 (Debt 2.42m / last Quarter total Stockholder Equity 28.9m)
Debt / EBITDA = -1.93 (Net Debt -8.29m / EBITDA -1.25m)
Debt / FCF = -0.71 (Debt 2.42m / FCF TTM -3.42m)
Total Stockholder Equity = 32.0m (last 4 quarters mean)
RoA = 0.77% (Net Income 348.0k, Total Assets 45.2m )
RoE = 1.09% (Net Income TTM 348.0k / Total Stockholder Equity 32.0m)
RoCE = -4.12% (Ebit -1.37m / (Equity 32.0m + L.T.Debt 1.36m))
RoIC = -4.30% (NOPAT -1.37m / Invested Capital 32.0m)
WACC = unknown (E(50.4m)/V(52.8m) * Re(6.84%)) + (D(2.42m)/V(52.8m) * Rd(none%) * (1-Tc(0.08)))
Shares Correlation 5-Years: 90.0 | Cagr: 0.16%
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -3.42m)
Revenue Correlation: -75.81 | Revenue CAGR: -6.24%
Rev Growth-of-Growth: 4.91
EPS Correlation: -3.71 | EPS CAGR: -34.14%
EPS Growth-of-Growth: -140.1
Additional Sources for NHTC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle